Ignite Creation Date:
2025-12-24 @ 5:09 PM
Ignite Modification Date:
2025-12-28 @ 6:32 PM
Study NCT ID:
NCT05039450
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-04-09
First Post:
2021-07-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Efruxifermin in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) (Symmetry)
Sponsor:
Akero Therapeutics, Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-07-30
Start Date Type:
ACTUAL
Primary Completion Date:
2023-08-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-05
Completion Date Type:
ESTIMATED
First Submit Date:
2021-07-29
First Submit QC Date:
None
Study First Post Date:
2021-09-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-07
Last Update Post Date:
2025-04-09
Last Update Post Date Type:
ACTUAL